Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Testing effectiveness (Phase 2)UnknownNCT04390945
What this trial is testing

Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 62
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Large-scale testing (Phase 3)Looking for participantsNCT07463573
What this trial is testing

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Qilu Pharmaceutical Co., Ltd. 466
Testing effectiveness (Phase 2)UnknownNCT05163483
What this trial is testing

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Who this might be right for
Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
Ruihua Xu 87
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Large-scale testing (Phase 3)Study completedNCT02395705
What this trial is testing

Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasm
Henan Cancer Hospital 528
Not applicableWithdrawnNCT03110939
What this trial is testing

Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer

Who this might be right for
Esophageal CancerLung CancerHyperthermic Perfusion
Henan Cancer Hospital
Not applicableStudy completedNCT07102329
What this trial is testing

BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)

Who this might be right for
Eosinophilic Esophagitis (EoE)
IRCCS San Raffaele 100,000
Not applicableUnknownNCT02017002
What this trial is testing

Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer

Who this might be right for
Surgical ProceduresMinimally InvasiveOperative+3 more
National Taiwan University Hospital 100
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Ended earlyNCT03122548
What this trial is testing

Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Aduro Biotech, Inc. 5
Not applicableEnrolling By InvitationNCT06990178
What this trial is testing

Adaptive Neoadjuvant Therapy for Esophageal Cancer

Who this might be right for
Esophageal CarcinomaNeoadjuvant Therapy
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 43
Testing effectiveness (Phase 2)UnknownNCT01697891
What this trial is testing

A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers

Who this might be right for
Head and Neck CancerDysphagia
McMaster University 35
Not applicableStudy completedNCT03335813
What this trial is testing

Endoesophageal Brachytherapy for Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 7
Early research (Phase 1)UnknownNCT03734926
What this trial is testing

ZSP1241 in Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaGastric Cancer+2 more
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 90
Not applicableStudy completedNCT00833625
What this trial is testing

FDG-PET-CT and Biomarkers in Esophageal Cancer

Who this might be right for
Gastrointestinal DiseaseEsophageal Cancer
M.D. Anderson Cancer Center 31
Not applicableUnknownNCT02209415
What this trial is testing

EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer

Who this might be right for
Esophageal CancerStomach CancerPancreatic Cancer
Michael Bau Mortensen 182
Not applicableStudy completedNCT07236320
What this trial is testing

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Yongtao Han 200
Next Page